Key Takeaways: The GLP-1 companion nutrition market is emerging rapidly due to widespread adoption of GLP-1 therapies (e.g., semaglutide, tirzepatide) for obesity and metabolic health management
Usually, it comes to the formula as part of a preservative blend as it's not enough on its own
In people with type 2 diabetes or specific cardiovascular risk factors, these can include improvements in insulin sensitivity, reduction in inflammatory markers, favourable effects on lipid profiles (particularly triglycerides), and potential cardiovascular benefits
This dual mechanism is what makes it the most effective weight loss medication ever studied in clinical trials
Pet specialty stores serve knowledgeable consumers seeking premium cognitive health solutions while online retail enables direct access to specialized formulations and convenient repeat purchasing
"Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase)." Journal of Affective Disorders, 2024
